ATE233406T1 - Verfahren zur bulk-anreicherung von einer zellpopulation oder zellsubpopulation - Google Patents

Verfahren zur bulk-anreicherung von einer zellpopulation oder zellsubpopulation

Info

Publication number
ATE233406T1
ATE233406T1 AT96943478T AT96943478T ATE233406T1 AT E233406 T1 ATE233406 T1 AT E233406T1 AT 96943478 T AT96943478 T AT 96943478T AT 96943478 T AT96943478 T AT 96943478T AT E233406 T1 ATE233406 T1 AT E233406T1
Authority
AT
Austria
Prior art keywords
particles
population
sample
subpopulation
eliminated
Prior art date
Application number
AT96943478T
Other languages
English (en)
Inventor
Norma S Kenyon
Thomas R Russell
Camillo Ricordi
Robert K Zwerner
Original Assignee
Biotransplant Inc
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotransplant Inc, Univ Miami filed Critical Biotransplant Inc
Application granted granted Critical
Publication of ATE233406T1 publication Critical patent/ATE233406T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96943478T 1995-11-13 1996-11-05 Verfahren zur bulk-anreicherung von einer zellpopulation oder zellsubpopulation ATE233406T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55826895A 1995-11-13 1995-11-13
PCT/US1996/017531 WO1997018473A1 (en) 1995-11-13 1996-11-05 Method and apparatus for bulk enrichment of a population or subpopulation of cells

Publications (1)

Publication Number Publication Date
ATE233406T1 true ATE233406T1 (de) 2003-03-15

Family

ID=24228865

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943478T ATE233406T1 (de) 1995-11-13 1996-11-05 Verfahren zur bulk-anreicherung von einer zellpopulation oder zellsubpopulation

Country Status (10)

Country Link
US (1) US6004743A (de)
EP (1) EP0877941B1 (de)
JP (1) JP2000500337A (de)
AT (1) ATE233406T1 (de)
CA (1) CA2236871A1 (de)
DE (1) DE69626418T2 (de)
DK (1) DK0877941T3 (de)
ES (1) ES2194125T3 (de)
PT (1) PT877941E (de)
WO (1) WO1997018473A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19710496A1 (de) * 1997-03-13 1998-09-17 Boehringer Mannheim Gmbh Verfahren zum Nachweis antigenspezifischer T-Zellen nach Anreicherung von mononukleären Zellpopulationen
US6623982B1 (en) * 1999-07-12 2003-09-23 Immunivest Corporation Increased separation efficiency via controlled aggregation of magnetic nanoparticles
US7316932B2 (en) * 2001-10-01 2008-01-08 Stemcell Technologies Inc. Method for separating cells
US9435799B2 (en) 2002-07-31 2016-09-06 Janssen Diagnostics, Inc. Methods and reagents for improved selection of biological materials
DE10323901A1 (de) * 2003-05-26 2005-01-05 Institut Virion/Serion Gmbh Verfahren und Testmittel zur Untersuchung und/oder zum Nachweis von Biomolekülen und/oder Wirkstoffen in Flüssigkeitsproben
US9790539B2 (en) 2004-06-30 2017-10-17 Russell Biotech, Inc. Methods and reagents for improved selection of biological molecules
CA2599975C (en) * 2005-03-03 2013-07-30 University Of North Dakota Surfaces coated with target-induced fluorescent compounds for detection of target elements
WO2007126151A1 (ja) * 2006-04-28 2007-11-08 Hitachi Maxell, Ltd. 機能性粒子およびそれを用いた標的物質の分離方法
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US10060911B2 (en) * 2011-08-19 2018-08-28 Protagen Aktiengesellschaft Method for diagnosis of high-affinity binders and marker sequences
EP2597153B1 (de) 2011-11-25 2016-10-05 Miltenyi Biotec GmbH Zelltrennverfahren
EP3068867B1 (de) 2013-11-16 2018-04-18 Terumo BCT, Inc. Zellenexpansion in einem bioreaktor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (de) 2014-09-26 2021-03-24 Terumo BCT, Inc. Geplante fütterung
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
JP7393945B2 (ja) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド 細胞増殖
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12227548B2 (en) 2018-11-19 2025-02-18 Dana-Farber Cancer Institute, Inc. Use of IRE1α-XBP1 signaling pathway biomarkers for modulating immune responses
EP4314244B1 (de) 2021-03-23 2025-07-23 Terumo BCT, Inc. Zellerfassung und -erweiterung
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928143A (en) * 1972-02-23 1975-12-23 Robert W Coughlin Method of carrying out enzyme-catalyzed reactions
US4115535A (en) * 1977-06-22 1978-09-19 General Electric Company Diagnostic method employing a mixture of normally separable protein-coated particles
US4487700A (en) * 1983-02-18 1984-12-11 Technicon Instruments Corporation Method and apparatus for separating lymphocytes from anticoagulated blood
US4752563A (en) * 1985-11-19 1988-06-21 Coulter Corporation Monoclonal antibody for recovery of leukocytes in human peripheral blood and method of recovery employing said monoclonal antibody
US5229268A (en) * 1986-07-14 1993-07-20 Abbott Laboratories Method for diagnostic immunoassay by solid phase separation
NO162946C (no) * 1987-08-21 1990-03-14 Otto Soerensen Anordning for magnetisk separasjon av celler.
US5238812A (en) * 1987-03-13 1993-08-24 Coulter Corporation Method and apparatus for rapid mixing of small volumes for enhancing biological reactions
ATE81724T1 (de) * 1987-11-09 1992-11-15 Becton Dickinson Co Verfahren zur analyse haematopoietischer zellen in einer probe.
US5256532A (en) * 1988-05-02 1993-10-26 Zynaxis Technologies, Inc. Methods, reagents and test kits for determination of subpopulations of biological entities
US5576185A (en) * 1994-04-15 1996-11-19 Coulter Corporation Method of positive or negative selection of a population or subpopulation of a sample utilizing particles and gravity sedimentation
US5474687A (en) * 1994-08-31 1995-12-12 Activated Cell Therapy, Inc. Methods for enriching CD34+ human hematopoietic progenitor cells

Also Published As

Publication number Publication date
EP0877941B1 (de) 2003-02-26
JP2000500337A (ja) 2000-01-18
WO1997018473A1 (en) 1997-05-22
PT877941E (pt) 2003-07-31
DK0877941T3 (da) 2003-05-05
US6004743A (en) 1999-12-21
DE69626418T2 (de) 2003-11-13
CA2236871A1 (en) 1997-05-22
EP0877941A1 (de) 1998-11-18
DE69626418D1 (de) 2003-04-03
ES2194125T3 (es) 2003-11-16
HK1016261A1 (en) 1999-10-29

Similar Documents

Publication Publication Date Title
DE69626418D1 (de) Verfahren zur bulk-anreicherung von einer zellpopulation oder zellsubpopulation
ATE292282T1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
Hart The role of asparagine-linked oligosaccharides in cellular recognition by thymic lymphocytes. Effects of tunicamycin on the mixed lymphocyte reaction
DE69941150D1 (de) Verfahren zur direkten auswahl von antigen-spezifischen t-zellen
SE9203320D0 (sv) A method of processing nucleic acid samples
ATE50647T1 (de) Verfahren zur quantifizierung von zellpopulationen bzw. subpopulationen sowie hierfuer geeignetes reagenz.
DE69332926D1 (de) Kontinuierliches zentrifugationsverfahren zum abtrennen von biologischen komponenten aus heterogenen zellpopulationen
EP1221342A3 (de) Verfahren zur Trennung von Zellen von einer Probe
DE69908795D1 (de) Verfahren zur isolierung von nukleinsäure und vorrichtung hierfür
DE69633740D1 (de) Verfahren zur auswahl einer population oder subpopulation einer probe unter verwendung von partikel-und schwerkraft -sedimentation
DE69636564D1 (de) Verfahren zur freisetzung von magnetischen teilchen, die an zelloberflächen gebunden sind
CA2279476A1 (en) Novel antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions
ATE75317T1 (de) Monoklonaler antikoerper zur wiedergewinnung von leukozyten in menschlichem peripherblut und gewinnungsverfahren unter verwendung dieses antikoerpers.
DE60037007D1 (de) Angereicherte zentralnervensystem-zellpopulationen
WO2004020597A3 (en) Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
ES2064888T3 (es) Procedimiento para la depuracion de yeso.
DE69323589D1 (de) Einen Basophilen bindender monoclonaler Antikörper, Verfahren zur Abtrennung von Basophilen, Verfahren für die Freisetzung von chemischen Vermittlern aus Basophilen, und Verfahren zur Prüfung der Freisetzung von von Basophilen abgeleiteten chemischen Vermittlern
PT82940A (de) Mit uberzugen versehene formkorper zur bindung von bioaffinen substanzen verfahren zu ihrer herstellung sowie ihre verwendung
ATE317117T1 (de) Trennungsverfahren einer chemischen oder biologischen verbindung in einer mischung von ähnlichen verbindungen durch diffusion in einem medium wie einem gel
AU1459392A (en) Method and apparatus for screening microscopic cells utilizing polarized light scatter techniques
AU5326198A (en) Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I
MX9604813A (es) Metodo de seleccion de una poblacion o subpoblacion de una muestra.
ES2011653A6 (es) Metodo y aparato para amezclar rapidamente pequenos volumenes con el fin de mejorar reacciones biologicas.
DE69029887D1 (de) Zentrifugalseparator, Verfahren zur Trennung von Tierzellen aus Tierzellen enthaltender Suspension mittels dieses Separators und Verfahren zur Züchtung von Tierzellen in Suspension mittels dieses Separators
ZA866956B (en) Methods for utilizing cell lines which lack human class ii histocompatibility antigens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0877941

Country of ref document: EP

REN Ceased due to non-payment of the annual fee